Therapeutic proteins

Home
Immunoassays
Modalities
Therapeutic proteins

Gyrolab platform supports therapeutic protein development

Therapeutic proteins are a major class of medicines, including monoclonal antibodies and other biologics used to treat cancer, metabolic disorders, and immune-related diseases. Their ability to target specific cells or biological pathways helps improve treatment precision and reduce unwanted side effects.

Developing these molecules comes with analytical challenges. Recombinant production introduces potential impurities such as host cell proteins (HCP), residual DNA, and Protein A. These must be monitored throughout development and manufacturing to ensure product quality and patient safety.

Gyrolab supports protein therapeutic workflows with automated immunoassays that help you detect impurities, characterize molecules, and generate reliable data across development and quality control.

Common classes of therapeutic proteins include:

Monoclonal antibodies (mAbs) – High specificity molecules that can target diseased cells or tissues. Often used alone or as part of antibody-drug conjugates (ADCs).
Enzymes – Used in replacement therapies for metabolic diseases such as phenylketonuria (PKU) and lactose intolerance, as well as in oncology and cardiovascular treatments.
Hormones and cytokines – Regulate cell signaling and biological responses, for example insulin and growth factors.
Coagulation factors – Used to treat bleeding disorders such as hemophilia.

Cell line development

Select high-performing clones based on productivity and impurity profiles. A wide dynamic range and high throughput allow you to screen more candidates with fewer assay adjustments.

Purification and processing

Detect host cell proteins (HCP), nucleic acids, and chromatography contaminants such as Protein A across varying sample types. High matrix tolerance helps maintain data quality even in complex samples.

Quality control

Monitor impurities and confirm product consistency in manufactured batches. Automated workflows support reproducible results aligned with regulatory expectations.